{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:14:07Z","timestamp":1787505247141,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,29]]},"DOI":"10.7759\/cureus.88989","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T15:03:23Z","timestamp":1753801403000},"source":"Crossref","is-referenced-by-count":1,"title":["Intravenous Iron Therapy in Patients Admitted With Acute Heart Failure and Iron Deficiency: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Victor","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Chac\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Vanegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Apuy Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel E","family":"Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021, 42:3599-726. 10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.07.015","article-title":"Iron deficiency in heart failure: an overview","volume":"7","author":"von Haehling S","year":"2019","unstructured":"von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD. Iron deficiency in heart failure: an overview. JACC Heart Fail. 2019, 7:36-46. 10.1016\/j.jchf.2018.07.015","journal-title":"JACC Heart Fail"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2023.03.025","article-title":"Iron deficiency in heart failure: a scientific statement from the Heart Failure Society of America","volume":"29","author":"Beavers CJ","year":"2023","unstructured":"Beavers CJ, Ambrosy AP, Butler J, et al.. Iron deficiency in heart failure: a scientific statement from the Heart Failure Society of America. J Card Fail. 2023, 29:1059-77. 10.1016\/j.cardfail.2023.03.025","journal-title":"J Card Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2810","article-title":"Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis","volume":"25","author":"Graham FJ","year":"2023","unstructured":"Graham FJ, Pellicori P, Kalra PR, Ford I, Bruzzese D, Cleland JG. Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis. Eur J Heart Fail. 2023, 25:528-37. 10.1002\/ejhf.2810","journal-title":"Eur J Heart Fail"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13737","article-title":"Acute heart failure and iron deficiency: a prospective, multicentre, observational study","volume":"9","author":"van Dalen DH","year":"2022","unstructured":"van Dalen DH, Kragten JA, Emans ME, et al.. Acute heart failure and iron deficiency: a prospective, multicentre, observational study. ESC Heart Fail. 2022, 9:398-407. 10.1002\/ehf2.13737","journal-title":"ESC Heart Fail"},{"key":"ref6","unstructured":"Cochrane Training. Cochrane Handbook for Systematic Reviews of Interventions. (2025). Accessed. February 20, 2025: https:\/\/training.cochrane.org\/handbook\/current."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski P","year":"2020","unstructured":"Ponikowski P, Kirwan BA, Anker SD, et al.. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020, 396:1895-904. 10.1016\/S0140-6736(20)32339-4","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx493.P5825","article-title":"Intravenous iron therapy in acute decompensated heart failure patients with iron deficiency anemia","volume":"38","author":"Youssef G","year":"2019","unstructured":"Youssef G, Kamal A, Diab R, Abdel Hamid M. Intravenous iron therapy in acute decompensated heart failure patients with iron deficiency anemia. Eur Heart J. 2019, 38:1231. 10.1093\/eurheartj\/ehx493.P5825","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12250","article-title":"Single-dose intravenous iron in Southeast Asian heart failure patients: a pilot randomized placebo-controlled study (PRACTICE-ASIA-HF)","volume":"5","author":"Yeo TJ","year":"2018","unstructured":"Yeo TJ, Yeo PS, Hadi FA, et al.. Single-dose intravenous iron in Southeast Asian heart failure patients: a pilot randomized placebo-controlled study (PRACTICE-ASIA-HF). ESC Heart Fail. 2018, 5:344-53. 10.1002\/ehf2.12250","journal-title":"ESC Heart Fail"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13584","article-title":"Iron deficiency and safety of ferric carboxymaltose in patients with acute heart failure. AHF-ID study","volume":"74","author":"Jacob J","year":"2020","unstructured":"Jacob J, Mir\u00f3 \u00d2, Ferre C, et al.. Iron deficiency and safety of ferric carboxymaltose in patients with acute heart failure. AHF-ID study. Int J Clin Pract. 2020, 74:e13584. 10.1111\/ijcp.13584","journal-title":"Int J Clin Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-019-03777-w","article-title":"Iron deficiency in heart failure, an underdiagnosed and undertreated condition during hospitalization","volume":"98","author":"Mistry R","year":"2019","unstructured":"Mistry R, Hosoya H, Kohut A, Ford P. Iron deficiency in heart failure, an underdiagnosed and undertreated condition during hospitalization. Ann Hematol. 2019, 98:2293-7. 10.1007\/s00277-019-03777-w","journal-title":"Ann Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.03.041","article-title":"Effects of total dose infusion of iron intravenously in\u00a0patients with acute heart failure and anemia (hemoglobin <13\u00a0g\/dl)","volume":"117","author":"Kaminsky BM","year":"2016","unstructured":"Kaminsky BM, Pogue KT, Hanigan S, Koelling TM, Dorsch MP. Effects of total dose infusion of iron intravenously in\u00a0patients with acute heart failure and anemia (hemoglobin &lt;13\u00a0g\/dl). Am J Cardiol. 2016, 117:1942-6. 10.1016\/j.amjcard.2016.03.041","journal-title":"Am J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13081250","article-title":"Ferric carboxymaltose in patients with acute decompensated heart failure and iron deficiency: a real-life study","volume":"13","author":"Capone F","year":"2023","unstructured":"Capone F, Cipriani A, Molinari L, et al.. Ferric carboxymaltose in patients with acute decompensated heart failure and iron deficiency: a real-life study. J Pers Med. 2023, 13:1250. 10.3390\/jpm13081250","journal-title":"J Pers Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/10742484211055639","article-title":"IV sodium ferric gluconate complex in patients hospitalized due to acute decompensated heart failure and iron deficiency","volume":"27","author":"Borreda I","year":"2022","unstructured":"Borreda I, Zukermann R, Epstein D, Marcusohn E. IV sodium ferric gluconate complex in patients hospitalized due to acute decompensated heart failure and iron deficiency. J Cardiovasc Pharmacol Ther. 2022, 27:10742484211055639. 10.1177\/10742484211055639","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13753","article-title":"Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction","volume":"9","author":"L\u00f3pez-Vilella R","year":"2022","unstructured":"L\u00f3pez-Vilella R, Lozano-Edo S, Arenas Mart\u00edn P, et al.. Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction. ESC Heart Fail. 2022, 9:133-45. 10.1002\/ehf2.13753","journal-title":"ESC Heart Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh TA","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023, 44:3627-39. 10.1093\/eurheartj\/ehad195","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/393739-intravenous-iron-therapy-in-patients-admitted-with-acute-heart-failure-and-iron-deficiency-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T15:03:25Z","timestamp":1753801405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/393739-intravenous-iron-therapy-in-patients-admitted-with-acute-heart-failure-and-iron-deficiency-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.88989","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,29]]}}}